​
Login / Signup
Mary Kate Anderson
ORCID
Publication Activity (10 Years)
Years Active: 2020-2022
Publications (10 Years): 4
Top Topics
Healthcare
Diffuse Large B Cell Lymphoma
Patient Reported
Peritoneal Dialysis
Top Venues
The Annals of pharmacotherapy
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Jenna Summerlin
,
Drew A Wells
,
Mary Kate Anderson
,
Zachery Halford
A Review of Current and Emerging Therapeutic Options for Hemophagocytic Lymphohistiocytosis.
The Annals of pharmacotherapy
(2022)
Mary Kate Anderson
,
Meredith Johnson
,
Lauren Thornburg
,
Zachery Halford
A Review of Selumetinib in the Treatment of Neurofibromatosis Type 1-Related Plexiform Neurofibromas.
The Annals of pharmacotherapy
(2021)
Mary Kate Anderson
,
Annie Torosyan
,
Zachery Halford
Brexucabtagene Autoleucel: A Novel Chimeric Antigen Receptor T-cell Therapy for the Treatment of Mantle Cell Lymphoma.
The Annals of pharmacotherapy
(2021)
Zachery Halford
,
Mary Kate Anderson
,
Matthew D Clark
Enfortumab Vedotin-ejfv: A First-in-Class Anti-Nectin-4 Antibody-Drug Conjugate for the Management of Urothelial Carcinoma.
The Annals of pharmacotherapy
55 (6) (2020)